VERGE GENOMICS
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
VERGE GENOMICS
Industry:
Biotechnology Genetics Health Care Machine Learning Neuroscience
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vergegenomics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
134.12 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Google Apps For Business
Similar Organizations
Clear Gene
Clear Gene improving diagnostics, from cancer to Covid.
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Engine Biosciences
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
OccamzRazor
OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.
PostEra
PostEra is a biotech company using its advances in machine learning for medicinal chemistry to get more cures to patients
Current Advisors List
Current Employees Featured
Founder
Investors List
Eli Lilly
Eli Lilly investment in Series B - Verge Genomics
Lifeforce Capital
Lifeforce Capital investment in Series B - Verge Genomics
Tao Capital Partners
Tao Capital Partners investment in Series B - Verge Genomics
Vulcan Capital
Vulcan Capital investment in Series B - Verge Genomics
Threshold
Threshold investment in Series B - Verge Genomics
ALS Investment Fund
ALS Investment Fund investment in Series B - Verge Genomics
BlackRock
BlackRock investment in Series B - Verge Genomics
Alumni Ventures
Alumni Ventures investment in Series B - Verge Genomics
Section 32
Section 32 investment in Series B - Verge Genomics
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series B - Verge Genomics
Newest Events participated
Participated in Y Combinator Summer 2015 Demo Day
on 2015-08-18 as exhibitor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-05-05 | Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer |
Official Site Inspections
http://www.vergegenomics.com Semrush global rank: 2.85 M Semrush visits lastest month: 5.68 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
